GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Clearday Inc (OTCPK:CLRD) » Definitions » Sloan Ratio %

Clearday (Clearday) Sloan Ratio % : -127.07% (As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Clearday Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Clearday's Sloan Ratio for the quarter that ended in Sep. 2023 was -127.07%.

Warning Sign:

When sloan ratio (-33.72)% higher than 25% or lower than -25%, earnings are more likely to be made up of accruals.

As of Sep. 2023, Clearday has a Sloan Ratio of -127.07%, indicating earnings are more likely to be made up of accruals.


Clearday Sloan Ratio % Historical Data

The historical data trend for Clearday's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clearday Sloan Ratio % Chart

Clearday Annual Data
Trend Dec20 Dec21 Dec22
Sloan Ratio %
-31.75 -35.63 -33.72

Clearday Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -127.07

Competitive Comparison of Clearday's Sloan Ratio %

For the Medical Care Facilities subindustry, Clearday's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clearday's Sloan Ratio % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Clearday's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Clearday's Sloan Ratio % falls into.



Clearday Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Clearday's Sloan Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Sloan Ratio=(Net Income (A: Dec. 2022 )-Cash Flow from Operations (A: Dec. 2022 )
-Cash Flow from Investing (A: Dec. 2022 ))/Total Assets (A: Dec. 2022 )
=(-14.308--3.978
-1.051)/33.751
=-33.72%

Clearday's Sloan Ratio for the quarter that ended in Sep. 2023 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Sep. 2023 )
=(-16.825--4.836
-0.979)/10.205
=-127.07%

Clearday's Net Income for the trailing twelve months (TTM) ended in Sep. 2023 was -8.727 (Dec. 2022 ) + -1.038 (Mar. 2023 ) + -4.593 (Jun. 2023 ) + -2.467 (Sep. 2023 ) = $-16.83 Mil.
Clearday's Cash Flow from Operations for the trailing twelve months (TTM) ended in Sep. 2023 was -1.714 (Dec. 2022 ) + -1.066 (Mar. 2023 ) + -1.731 (Jun. 2023 ) + -0.325 (Sep. 2023 ) = $-4.84 Mil.
Clearday's Cash Flow from Investing for the trailing twelve months (TTM) ended in Sep. 2023 was 1.08 (Dec. 2022 ) + -0.018 (Mar. 2023 ) + 0.155 (Jun. 2023 ) + -0.238 (Sep. 2023 ) = $0.98 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Clearday  (OTCPK:CLRD) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Sep. 2023, Clearday has a Sloan Ratio of -127.07%, indicating earnings are more likely to be made up of accruals.


Clearday Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Clearday's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Clearday (Clearday) Business Description

Traded in Other Exchanges
N/A
Address
8800 Village Drive, Suite 106, San Antonio, TX, USA, 78217
Clearday Inc is a non-acute health care services company. It operates four residential care facilities and a daycare center that serve primarily older Americans and persons facing cognitive issues such as Alzheimer's and other forms of dementia. Some of its products include Clearday Network, Clearday at Home, Clearday Clubs, and memory care America.
Executives
James Walesa director, 10 percent owner, officer: Chief Executive Officer 1460 RENAISSANCE DR., #212, PARK RIDGE IL 60068
Watson Robert Glen Jr. director 602 ALTA AVENUE, SAN ANTONIO TX 78217
Billie Jay Parrish director, officer: Chief Operating Officer C/O CLEARDAY, INC., 8800 VILLAGE DRIVE, SUITE 106, SAN ANTONIO TX 78217
Elizabeth M. Caveness director 408 EAST CREEKVIEW DRIVE, HAMPSTEAD NC 28443
Alan H Channing director 263 W END AVE., APT 3A, NEW YORK NY 10023
Gary Sawina officer: Executive Vice President 17302 FOUNTAIN VIEW DRIVE, SAN ANTONIO TX 78248
Linda Carrasco officer: President Memory Care America 126 STEEL VALLEY DRIVE, BOERNE TX 78006
Richard M. Morris officer: Executive Vice President 11 AMALFI DRIVE, CORTLANDT MANOR NY 10567
Allied Integral United, Inc. 10 percent owner 2211 NW MILITARY HIGHWAY, SUITE 201, SAN ANTONIO TX 78213
Julia Suzanne Johnson director 1001 RIDDER PARK STREET, SAN JOSE CA 95131
Kopp Family Office, Llc 10 percent owner 8500 NORMANDALE LAKE BOULEVARD, SUITE 475, BLOOMINGTON MN 55437
Dan L Halvorson director 4780 EASTGATE MALL, SAN DIEGO CA 92121
Kenneth E Pfeiffer officer: Vice President Engineering 460 WARD DRIVE, SANTA BARBARA CA 93111
Thomas R Giunta officer: VP Engineering 460 WARD DRIVE, SANTA BARBARA CA 93111
Xiaoxiong Zhang 10 percent owner 3/F, BLOCK B, 11 LANGSHAN RD, HI-TECH INDUSTRIAL PK, NANSHAN DISTRICT, SHENZHEN F4 518057

Clearday (Clearday) Headlines

From GuruFocus

Clearday Inc. Announces Application to Uplist to OTCQX

By PRNewswire PRNewswire 03-03-2022

Clearday Moves Forward with Robotic Deployment

By PRNewswire PRNewswire 06-21-2022

Emerging Markets Report: No One Should be Alone

By GuruFocusNews GuruFocusNews 04-04-2022

Clearday Retains ClearThink Capital to Explore Unlocking Value with SPACs

By Stock market mentor Stock market mentor 01-26-2023

Emerging Markets Report: Something in Sanskrit

By GuruFocusNews GuruFocusNews 06-28-2022

Emerging Markets Report: Something in Sanskrit

By GuruFocusNews GuruFocusNews 07-08-2022

Emerging Markets Report: Something in Sanskrit

By GuruFocusNews GuruFocusNews 06-18-2022